This guide provides an overview of how clinical trials are conducted in Spain, including the regulatory environment, ethics review process, site infrastructure, and the advantages of selecting Spain as a clinical research destination.
This guide explains how sponsors run clinical trials in France, including the regulatory framework, ethics review process, site infrastructure, and why France stands out as a leading clinical research destination.
This guide outlines how clinical trials are conducted in Germany, covering the regulatory landscape, ethics approval process, clinical research infrastructure, and the strategic benefits of choosing Germany for clinical development.
This guide outlines how sponsors conduct clinical trials in Italy, covering the regulatory landscape, ethics approval process, site network, and the key factors that make Italy a strong choice for clinical development in Europe.
This guide explores the clinical trial landscape in the UK, highlighting how studies are approved and managed, the role of regulatory and ethics bodies, the structure of clinical research sites, and the factors that position the UK as a key location for clinical research.
Clinical trials in the Netherlands are known for fast start-up timelines, efficient regulatory processes, and high-performing sites. This guide explains the approval process, infrastructure, and key advantages of clinical trials in the Netherlands.
This guide explores how clinical trials are conducted in Belgium, covering the regulatory framework, ethics review process, site infrastructure, and why Belgium stands out as a specialist hub for oncology and rare disease research in Western Europe.
This guide explains how clinical trials are conducted in Switzerland, covering the regulatory framework under Swissmedic, ethics review process, Phase I site expertise, and why Switzerland is a leading destination for precision medicine and first-in-human studies in Europe.
This guide provides an overview of how clinical trials are conducted in Portugal, including the regulatory environment, ethics review process, site infrastructure, and the factors that make Portugal a cost-effective and competitive option for Southern European clinical development.
This guide explains how clinical trials are conducted in Denmark, covering the regulatory framework, ethics approval process, national registry infrastructure, and why Denmark is recognised for fast start-up timelines and high data quality in clinical research.
This guide outlines how clinical trials are conducted in Sweden, covering the regulatory landscape, ethics review process, academic site network, and the strategic advantages of Sweden’s registry-linked research infrastructure and world-class university hospitals.
This guide outlines how clinical trials are conducted in Austria, covering the regulatory landscape, ethics approval process, academic medical infrastructure, and the strategic advantages of selecting Austria as a Central European clinical research destination.
This guide provides an overview of how clinical trials are conducted in Poland, including the regulatory environment, ethics review process, site infrastructure, and the key considerations for leveraging Poland’s large patient pool and cost-competitive research environment.
This article explores how Western and Eastern Europe compare as clinical trial destinations, and how CTIS is reshaping country selection. It reviews differences in regulatory processes, recruitment dynamics, site infrastructure, and costs, while highlighting a shift toward operational performance, patient access, and therapeutic expertise.
